Smoking status and risk for recurrent coronary events after myocardial infarction

Thomas D Rea1, Susan R Heckbert, Robert C Kaplan

  • 1University of Washington, Cardiovascular Health Research Unit, Metropolitan Park, East Tower, 1730 Minor Avenue, Suite 1360, Seattle, WA 98101, USA. rea123@u.washington.edu

Annals of Internal Medicine
|September 17, 2002
PubMed

Insights

Smoking after myocardial infarction increases recurrent coronary events. Quitting smoking significantly reduces this risk, returning it to non-smoker levels within three years.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The impact of smoking and smoking cessation on outcomes after myocardial infarction (MI) requires further investigation.
  • Understanding these factors is crucial for patient management and public health strategies.

Purpose of the Study:

  • To determine the association between smoking status and the risk of recurrent coronary events following a first myocardial infarction.
  • To evaluate the impact of smoking cessation on this risk.

Main Methods:

  • A retrospective, population-based cohort study was conducted using data from a health maintenance organization (1986-1996).
  • The study included 2619 patients who survived hospitalization after their first MI.
  • Cox proportional hazards regression analysis was used to assess relative risks (RR) for recurrent coronary events based on smoking status (nonsmokers, former smokers, quitters, active smokers).

Main Results:

  • Active smokers had a 1.51 times higher risk of recurrent coronary events compared to nonsmokers (RR = 1.51; 95% CI, 1.10 to 2.07).
  • Former smokers had a slightly elevated but not statistically significant risk (RR = 1.17; 95% CI, 0.93 to 1.43).
  • For patients who quit smoking after MI, the risk of recurrent events decreased with longer cessation duration, reaching levels comparable to nonsmokers by 36 months or more (P = 0.01 for trend).

Conclusions:

  • Smoking is significantly associated with an increased risk of recurrent coronary events after myocardial infarction.
  • Smoking cessation following MI is associated with a significant reduction in the risk of recurrent events.
  • Achieving 3 years of smoking cessation after MI can normalize the risk of recurrent coronary events to that of never-smokers.
Abstract

Related Concept Videos

Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...